loading

Finanzdaten der Viridian Therapeutics Inc-Aktie (VRDN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
4.17%
0.075
0.072 0.086 0.072 0.072
Operating Expenses
13.74%
106.84
93.94 83.57 72.26 55.97
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
13.74%
106.84
93.94 83.57 72.26 55.97
Operating Income/Loss
13.74%
-106.77
-93.87 -83.48 -72.19 -55.90
Nonoperating Income/Loss
13.26%
6.032
6.954 6.791 7.194 7.355
Income/Loss From Continuing Operations Before Tax
100.09%
0.075
-86.91 0.086 -64.99 -48.54
Income/Loss From Continuing Operations After Tax
15.90%
-100.73
-86.91 -76.69 -64.99 -48.54
Net Income/Loss
15.90%
-100.73
-86.91 -76.69 -64.99 -48.54
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):